Mansukh Mandaviya said surplus vaccines will be used to fulfill “India’s commitment to the world for the collective fight against COVID-19”, but vaccination of Indians will remain the government’s “top priority”.
The halt in exports has left many developing countries without adequate supplies and delayed vaccines for millions of people.
Before stopping exports, India donated or sold 66 million doses of vaccine to nearly 100 countries.
Mandaviya did not specify how many doses would be exported. He said monthly production of coronavirus vaccine in India has more than doubled since April and is expected to rise to 300 million doses in October.
“We will help the world and live up to our responsibility to COVAX,” he said.
Serum Institute of India, the world’s largest vaccine manufacturer, currently produces around 150 million doses of AstraZeneca AZN,
vaccine each month, an increase of more than double since April.
Inoculations from India have increased in recent months.
A country of nearly 1.4 billion people, India has administered more than 800 million doses of vaccines. It administered at least one dose to over 62% of the eligible adult population and two doses to approximately 22%.